These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1347992)

  • 1. Blacks, schizophrenia, and neuroleptic treatment.
    McLeod-Bryant SA
    Arch Gen Psychiatry; 1992 Feb; 49(2):164-5. PubMed ID: 1347992
    [No Abstract]   [Full Text] [Related]  

  • 2. The costs of drugs for schizophrenia.
    Freedman R; Carpenter WT; Davis JM; Goldman HH; Tamminga CA; Thomas M
    Am J Psychiatry; 2006 Dec; 163(12):2029-31. PubMed ID: 17151146
    [No Abstract]   [Full Text] [Related]  

  • 3. The clinical use of antipsychotic medications.
    Coyle JT
    Med Clin North Am; 1982 Sep; 66(5):993-1009. PubMed ID: 6127455
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative effectiveness of antipsychotic drugs.
    Meibach RC
    Am J Psychiatry; 2003 Mar; 160(3):589-90; author reply 592-3. PubMed ID: 12611851
    [No Abstract]   [Full Text] [Related]  

  • 5. Lessons from each drug trial.
    Marder SR
    Am J Psychiatry; 2007 Mar; 164(3):375-6. PubMed ID: 17329457
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuroleptic malignant syndrome. Successful treatment with bromocriptine.
    Mueller PS; Vester JW; Fermaglich J
    JAMA; 1983 Jan; 249(3):386-8. PubMed ID: 6129331
    [No Abstract]   [Full Text] [Related]  

  • 7. Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia.
    Johnson DA
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):13-21. PubMed ID: 6143743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis-induced extrapyramidalism in a patient on neuroleptic treatment.
    Rejón Altable C; Rodríguez Urrutia A; Carrión Martínez MI
    J Clin Psychopharmacol; 2005 Feb; 25(1):91-2. PubMed ID: 15643106
    [No Abstract]   [Full Text] [Related]  

  • 9. Higher frequency of neuroleptic-induced dystonia in mania than in schizophrenia.
    Nasrallah HA; Churchill CM; Hamdan-Allan GA
    Am J Psychiatry; 1988 Nov; 145(11):1455-6. PubMed ID: 2903686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic responsiveness in siblings concordant for schizophrenia.
    DeLisi LE; Dauphinais D
    Arch Gen Psychiatry; 1989 May; 46(5):477. PubMed ID: 2565710
    [No Abstract]   [Full Text] [Related]  

  • 11. Practical considerations in the use of depot neuroleptics for the treatment of schizophrenia.
    Johnson DA
    Br J Hosp Med; 1977 Jun; 17(6):546-58. PubMed ID: 18242
    [No Abstract]   [Full Text] [Related]  

  • 12. The handwriting test as an aid to neuroleptic dosage.
    Küstner U; Müller-Oerlinghausen B
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S34-41. PubMed ID: 2878893
    [No Abstract]   [Full Text] [Related]  

  • 13. Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review.
    Gao K; Kemp DE; Ganocy SJ; Gajwani P; Xia G; Calabrese JR
    J Clin Psychopharmacol; 2008 Apr; 28(2):203-9. PubMed ID: 18344731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of schizophrenia].
    Houy-Durand E; Thibaut F
    Rev Prat; 2002 Jun; 52(11):1213-20. PubMed ID: 12148207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin response and extrapyramidal side effects during propranolol and neuroleptic drugs treatment in chronic schizophrenic patients.
    Elizur A; Segal S; Yeret A; Ben-David M
    Isr Ann Psychiatr Relat Discip; 1979 Dec; 17(4):318-27. PubMed ID: 44877
    [No Abstract]   [Full Text] [Related]  

  • 16. Zotepine, a neuroleptic drug with a bipolar therapeutic profile.
    Dieterle DM; Ackenheil M; Müller-Spahn F; Kapfhammer HP
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):52-7. PubMed ID: 2883683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurologic side effects in neuroleptic-naïve patients treated with haloperidol or risperidone.
    Windhaber J; Urbanits S; Grisold W
    Neurology; 2000 Apr; 54(7):1543-4. PubMed ID: 10751282
    [No Abstract]   [Full Text] [Related]  

  • 18. [Difficulties in neuroleptic treatment of schizophrenic patients].
    Woggon B
    Schweiz Arch Neurol Psychiatr (1985); 1985; 136(1):55-9. PubMed ID: 2579426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotensin receptor agonists and antagonists for schizophrenia.
    Robertson VB; Wilson MS
    Am J Psychiatry; 2005 Mar; 162(3):634; author reply 635. PubMed ID: 15741502
    [No Abstract]   [Full Text] [Related]  

  • 20. Advantages and disadvantages of depot-neuroleptics as maintenance medication for chronic schizophrenics.
    Möller HJ; Kissling W
    Clin Neuropharmacol; 1986; 9 Suppl 4():259-62. PubMed ID: 2882841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.